INNOVATIVE APPROACHES TO REPRODUCTIVE FUNCTION RECOVERY IN PATIENTS WITH UTERINE MYOMA
- Autores: Bezhenar V.F.1, Komlichenko E.V.2, Yarmolinskaya M.I.3, Dedul A.G.2, Sheveleva T.S.1, Malushko A.V.2, Kalinina E.A.2, Zubareva T.M.4, Gamzatova Z.K.4, Kondrat’ev A.A.1
-
Afiliações:
- Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
- University Clinic, Saint Petersburg State University
- D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
- V.A. Almazov North-Western Federal Medical Research Center, Ministry of Health of Russia
- Edição: Nº 1 (2016)
- Páginas: 80-87
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247662
- ID: 247662
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Palavras-chave
Texto integral
Sobre autores
Vitaly Bezhenar
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Email: bez-vitaly@yandex.ru
MD, Professor, Head of the Department of Obstetrics
Eduard Komlichenko
University Clinic, Saint Petersburg State University
Email: e_komlichenko@mail.ru
MD, Professor Saint-Petersburg 198103, Fontanka Embankment 154, Russia
Maria Yarmolinskaya
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
Email: m.yarmolinskaya@gmail.com
Leading researcher of the Department of Reproduction Endocrinology Saint-Petersburg 199034, Mendeleevskaya line 154, Russia
Anna Dedul
University Clinic, Saint Petersburg State University
Email: deag@list.ru
MD, PhD, obstetrician-gynecologist in the Department of Family Planning and Human Reproduction Saint-Petersburg 198103, Fontanka Embankment 154, Russia
Tatyana Sheveleva
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Email: sheveleva.t@bk.ru
MD, Chief of the Gynecology Department, Clinic of Obstetrics and Gynecology
Anton Malushko
University Clinic, Saint Petersburg State University
Email: a-malushko@mail.ru
MD Saint-Petersburg 198103, Fontanka Embankment 154, Russia
Evgenia Kalinina
University Clinic, Saint Petersburg State University
Email: evgenia_kalinina@list.ru
MD Saint-Petersburg 198103, Fontanka Embankment 154, Russia
Tatiana Zubareva
V.A. Almazov North-Western Federal Medical Research Center, Ministry of Health of Russia
Email: Tamizu@yandex.ru
MD
Zainab Gamzatova
V.A. Almazov North-Western Federal Medical Research Center, Ministry of Health of Russia
Email: Tamizu@yandex.ru
MD, Licentiate
Anton Kondrat’ev
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Email: Kondratyev90tony@rambler.ru
Assistant professor of the Department of Obstetrics
Bibliografia
- Мато Т. Translational research in women’s health: from bedside to bench and from bench to bedside. Int. J. Gynecol. Obstet. 2010; 109(2): 83-4.
- Donnez J., Tatarchuk T.T., Bouchard P, Puscasiu L., Nataliya F, Zakharenko N.F., Ivanova T. et al.; PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery. N. Engl. J. Med. 2012; 366(5): 409-20.
- Duhan N., Sirohriwal D. Uterine myomas revisited. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010; 152(2): 119-25.
- Oliveira F.G., Abdelmassih V.G., Diamond M.P, Dozortsev D., Melo N.R., Abdelmassih R. Impact of subserosal and intramural uterine fibroids that do not distort the endometrial cavity on the outcome of in vitro fertilization- intracytoplasmic sperm injection. Fertil. Steril. 2004; 81(3): 582-7.
- Donnez J-, Jadoul P What are the implications of myomas on fertility? A need for a debate? Hum. Reprod. 2002; 17(6): 1424-30.
- Donnez I-, Pirard C., Smets M., Polet R., Feger C., Squifflet J. Unusual growth of a myoma during pregnancy. Fertil. Steril. 2002; 78(3): 632-3.
- Surrey E.S. Impact of intramural leiomyomata on in-vitro fertilization- embryo transfer cycle outcome. Curr. Opin. Obstet. Gynecol. 2003; 15(3): 239-42.
- Tamura К., Нага T, Kutsukake M., Iwatsuki K., Yanagida M., Yoshie M., Kogo H. Expression and the biological activities of insulin-like grown factorbinding protein related protein 1 in rat uterus during the periimplantation period. Endocrinology. 2004; 145(11): 5243-51.
- Seracchioli R., Rossi S., Govoni F, Rossi E., Venturoli S., Bulletti C., Flamigni C. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum. Reprod. 2000; 15(12): 2663-8.
- Zapata L.B., Whiteman M.K., Tepper N.K., Jamieson D.J., Marchbanks P.A., Curtis KM. Intrauterine devices among women with uterine fibroids: a systematic review. Contraception. 2010; 82(1): 41-5.
- Yin P, Lin Z., Reierstad S., Wu J., Ishikawa H., Marsh E.E. et al. Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells. Cancer Res. 2010; 70(4): 1722-30.
- Cardozo E.R., GarkA.D., Banks N.K., Henne M.B., Stegmann B.J., Segars J.H. The estimated annual cost of uterine leiomyoma in the United States. Am. J. Obstet. Gynecol. 2012; 206(3): 211. el-9.
- Wise L.A., Palmer J.R., Harlow B.L., Spiegelman D., Stewart EA., Adams- CampbellL.L., Rosenberg L. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am. J. Epidemiol. 2004;159(2): 113-6.
- Cha P.C., Takahashi A., Hosono N., Low S.K., Kamatani N., Kubo M., Nakamura Y. A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids. Nat. Genet. 2011; 43(5): 447-50.
- Baschinsky D.Y., Isa A., Niemann T.H., Prior T.W., Lucas J.G., Frankel W.L. Diffuse Leiomyomatosis of the uterus. A case report with clonality analysis. Hum. Pathol. 2000; 31(11): 1430-2.
- Ingraham S.E., Lynch R.A., Kathiresan S., Buckler A.J., Menon A.G. hREC2, a RAD51-like gene, is disrupted by t( 12; 14) (ql5;q24.1) in a uterine leiomyoma. Cancer Genet. Cytogenet. 1999; 115: 56-61.
- Dubuisson J.B., Chapron C., Fauconnier A., Babaki-Fard K. Laparoscopic myomectomy fertility results. Ann. N. Y. Acad. Sci. 2001; 943: 269-75.
- Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons. Myomas and reproductive function. Fertil. Steril. 2008; 90(Suppl.): S125-30.
- Gar к NA., Mumford S.L., Segars J.H. Reproductive impact of MRI-guided focused ultrasound surgery for fibroids: a systematic review of the evidence. Curr. Opin. Obstet. Gynecol 2014; 26(3): 151-61.
- Gupta J.K., Sinha A., Lumsden M.A., Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst. Rev. 2012; (5): CD005073.
- Sayed G.H., Zakherah M.S., El-Nashar SA., Shaaban MM. A randomized clinical trial of a levonorgestrel- releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia. Int. J. Gynaecol. Obstet. 2011; 112(2): 126-30.
- Rein D. T, Schmidt T, Fleisch M., WagnerR., Janni JUMulti-modale Behandlung des Uterus myomatosus. Frauenarzt. 2009; 50: 752-8.
- Pritts EA. Fibroids and infertility: a systematic review of the evidence. Obstet. Gynecol. Surv. 2001; 56(8): 483-91.
- Bosteels J., Kasius J., Weyers S., Broekmans F.J., Mol B.W., D’Hooghe T.M. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst. Rev. 2013; (1): CD009461.
- Metwally M., Cheong Y.C., Horne A.W. Surgical treatment of fibroids for subfertility. Cochrane Database Syst. Rev. 2012; (11): CD003857.
- Palomba S., Zupi E., Falbo A., Russo T, MarconiD., Tolino A. et al. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes. Fertil Steril 2007; 88(4): 933-41.
- Thomas R.L., Winkler N., Carr B.R., Doody K.M., Doody K.J. Abdominal myomectomy-a safe procedure in an ambulatory setting. Fertil. Steril 2010; 94(6): 2277-80.
- Wen K.C., Chen Y.J., Sung P.L., WangP.H. Comparing uterine fibroids treated by myomectomy through traditional laparotomy and 2 modified approaches: ultraminilaparotomy and laparoscopically assisted ultraminilaparotomy. Am. J. Obstet. Gynecol. 2010; 202(2): 144. el-8.
- De Wilde R.L., Hucke J. Brauchen wir die Uterusarterien Embolisation. Frauenarzt. 2006; 47: 415.
- Chwalisz K, Perez M.C., Demanno £)., Winkel C, Schubert G., Eiger W Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr. Rev. 2005; 26(3): 423-38.
- Gohi A.Z., Lacruz R.L., Paricio J.J., Hernandez Rivas F.J. The levonorgestrel intrauterine system as an alternative to hysterectomy for the treatment of idiopathic menorrhagia. Gynecol. Endocrinol. 2009; 25(9): 581-6.
- Hurskainen R., Teperi J., Rissanen P, Aalto A.M., Grenman S., Kivela A. et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004; 291(12): 1456-63.
- Hurskainen R., Teperi J., Rissanen P, Aalto A.M., Grenman S., Kivela A. et al. Quality of life and cost-effectiveness of levonorgestrel releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet. 2001; 357(9252): 273-7.
- Ldhteenmaki P, Haukkamaa M., Puolakka J., Riikonen U., Sainio S., Suvisaari J., Nilsson C.G. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ 1998; 316(3178): 1122-6.
- Donnez J., Tomaszewski J., Vazquez F., Bouchard P, Lemieszczuk В., Ваго F. et al.; PEARL II Study Group. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N. Engl. J. Med. 2012; 366(5): 421-32.
- Lethaby A., Vollenhoven B., Sowter M. Preoperative Gn-Rg-analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst. Rev. 2001; (2): CD000547.
- Nisolle M., Gillerot S., Casanas-Roux F, Squifflet J., Berliere M., Donnez J- Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and В in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophinreleasing hormone agonist therapy. Hum. Reprod. 1999; 14(11): 2844-50.
- Osinovskaya N., Ivaschenko T.S., Dolinskii A.K., Sultanov I.U., Ghimbovskaya S.D., Hoffman E.P, Bezhenar V.F., Baranov V.S. MED-12 Gene mutations in women with uterine myoma. Russian J. Genet. 2013; 49(12): 1245-9.
- Chabbert-Buffet N., Meduri G., Bouchard P, Spitz 1-М. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum. Reprod. Update. 2005; 11(3): 293-307.
- Levens E.D., Potlog-Nahari C., Armstrong A.Y., Wesley R., Premkumar A., Blithe D.L. et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet. Gynecol. 2008; 111(5): 1129-36.
- Nieman L.K, Blocker W., Nansel T, Mahoney S., Reynolds J., Blithe D. et al. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase lib study. Fertil. Steril. 2011; 95(2): 767-72. el-2.
- Spitz TM. Progesterone antagonists and progesterone receptor modulators: an overview. Steroids. 2003; 68: 981-93.